Foresight Diagnostics

Foresight Diagnostics is a venture-backed molecular diagnostics company focused on developing non-invasive cancer detection technologies. Their mission is to improve the lives of cancer patients worldwide by offering cell-free DNA-based liquid biopsy tests that are rooted in novel and proprietary methods developed at Stanford University. Foresight's unique approach enables the earlier detection of smaller tumors, which allows for more personalized and effective cancer treatment strategies. They have a team of experts in molecular biology, bioinformatics, and Next Generation Sequencing (NGS), and maintain a dynamic and fast-paced work environment.

Foresight's flagship product is Foresight CLARITY™, an ultra-sensitive minimal residual disease (MRD) test that utilizes PhasED-Seq™ technology to detect circulating tumor DNA (ctDNA). This technology delivers a higher degree of sensitivity than conventional methods, allowing for the detection of cancer relapse up to 200 days earlier. Foresight has a strong focus on research and development, partnering with leading cancer centers, universities, and pharmaceutical companies to generate clinical evidence and validate the utility of their technology across a range of tumor types.

Foresight Diagnostics offers flexibility in their work arrangements, allowing for fully onsite, hybrid, or remote work depending on the specific role and individual preference. Some roles require regular onsite work, while others offer the opportunity to work remotely, though remote workers may be required to travel to the Colorado headquarters quarterly. Additionally, while most positions adhere to standard business hours, some roles may require flexibility to work diverse schedules, including evenings, weekends, and holidays.

Foresight Diagnostics offers a comprehensive benefits package to its employees, including paid vacation, sick time, and parental leave. They also provide health insurance (medical, dental, and vision), life insurance, disability coverage, flexible spending accounts, and a 401k with company match. In addition, certain positions are eligible for equity offerings.

Foresight Diagnostics is a venture-backed molecular diagnostics company developing non-invasive cancer detection technologies to improve the lives of patients worldwide. Their cell-free DNA based liquid biopsy tests, rooted in novel and proprietary methods developed at Stanford University, enable the earlier detection of smaller tumors, leading to more personalized and effective cancer treatment strategies.

Foresight Diagnostics fosters a dynamic and fast-paced work environment where employees are encouraged to make high-impact contributions and experience rapid professional growth. The company values collaboration, innovation, and a dedication to improving the lives of cancer patients. This environment is characterized by a strong emphasis on scientific excellence, a commitment to quality, and a culture of continuous improvement.

Foresight Diagnostics is committed to building a diverse, equitable, and inclusive workplace where everyone feels valued, respected, and empowered to contribute their unique perspectives and talents. The company actively strives to create an environment that embraces differences, promotes equal opportunities for all, and fosters a sense of belonging for every employee. Foresight Diagnostics recognizes the importance of a diverse workforce in driving innovation and achieving its mission to improve the lives of cancer patients worldwide.